Falberg Kathryn E
SEC-identified person · CIK 1206977 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arcus Biosciences, Inc. RCUS | Director | filed 2018 - 2026 |
| Panacea Acquisition Corp PANA | Director | filed 2021 - 2026 |
| Trade Desk, Inc. TTD | Director | filed 2016 - 2026 |
| Tricida, Inc. TCDA | Director | filed 2018 - 2022 |
| Urogen Pharma Ltd. URGN | Director | filed 2019 - 2021 |
| Aimmune Therapeutics, Inc. AIMT | Director | filed 2015 - 2020 |
| Sio Gene Therapies Inc. SIOX | Director | filed 2017 - 2017 |
| Medivation, INC. MDVN.OB | Director | filed 2013 - 2016 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2016 - 2016 |
| Atyr Pharma INC LIFE | Director | filed 2015 - 2016 |
| Halozyme Therapeutics, INC. Halo | Director | filed 2007 - 2016 |
| Jazz Pharmaceuticals plc JAZZ | SVP and CFO | filed 2009 - 2014 |
| QLT INC/BC QLTI | Director | filed 2009 - 2011 |
| Oruka Therapeutics, Inc. ORKA | CFO and COO | filed 2009 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.